human clinical trials
Scope
Date
~
-
Bio & Pharma
Celltrion unveils cancer medicine to expand new drug pipelines
South Korea’s leading biosimilar drug developer Celltrion Inc. on Sunday unveiled an anticancer medicine to expand new pipelines and accelerat...
Apr 28, 2025 (Gmt+09:00)
-
Bio & Pharma
SillaJen: First to use lab-grown human tissue to find best cancer drug dose
South Korean biotechnology firm SillaJen Inc. is pioneering a new approach to determine the best dose for a cancer drug combination in clinical tria...
Mar 18, 2025 (Gmt+09:00)
-
Bio & Pharma
President of Latvia visits S.Korea's Daan Cancer Lab
Daan Cancer Laboratory under Severance Hospital said on Thursday it signed a memorandum of understanding (MOU) with the Latvian government to streng...
Nov 28, 2024 (Gmt+09:00)
-
Banking & Finance
KB Financial first in Korean banking to achieve ISO human capital standard
South Korea’s KB Financial Group said on Tuesday that it had obtained ISO 30414 certification, becoming the first in the domestic financial se...
Nov 06, 2024 (Gmt+09:00)
-
Korean startups
Mediaiplus aims to be the Amazon of clinical trials
Mediaiplus Inc., South Korea’s only provider of data analytics and contract research organization (CRO) matching services for clinical trials,...
Nov 01, 2024 (Gmt+09:00)
-
Tech, Media & Telecom
LG’s telecom unit looks to lure foreigners with more K-pop-themed shops
LG Uplus Corp., South Korea’s No. 3 mobile carrier, is set to lure foreign customers by opening K-pop-themed stores in the country's major sho...
Sep 06, 2024 (Gmt+09:00)
-
Artificial intelligence
Naver’s HyperCLOVA X Vision proves a picture is worth a thousand words
A picture is worth a thousand words, as the adage goes, stressing the power of vision over text.People also say eyes are windows to the soul, emphas...
Aug 22, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets FDA nod for Keytruda copy's phase 3 clinical trials
Celltrion Inc., South Korea’s biosimilar giant, will proceed with phase 3 trials for global blockbuster drug Keytruda’s copycat CT-P51, ...
Aug 12, 2024 (Gmt+09:00)
-
Retail
Hyundai Premium Outlet runs AI Human for foreign customer
South Korea's Hyundai Premium Outlet announced on Tuesday that it will trial the artificial intelligence (AI) service AI Human at its Songdo store u...
Jul 23, 2024 (Gmt+09:00)
-
Insurance
Kyobo Lifeplanet, FWD Hong Kong to collaborate on GenAI
South Korea's Kyobo Lifeplanet Life Insurance Co. announced on Friday that it signed a memorandum of understanding with Hong Kong-based insurer FWD ...
Jul 12, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion eyes M&A in Europe, $3.3 bn Zymfentra sales: chairman
WASHINGTON, D.C. – South Korean biosimilar giant Celltrion Inc. is accelerating its push to transform into a novel drug developer, going after...
May 23, 2024 (Gmt+09:00)
-
Beauty & Cosmetics
Cosmax develops smart color matching AI system
Cosmax Inc., South Korea's largest cosmetics manufacturer specializing in original design manufacturing (ODM), built a makeup product development ...
May 23, 2024 (Gmt+09:00)
-
ESG
POSCO Future M publishes responsible minerals report
South Korea's POSCO Future M Co. announced on Tuesday that it released a responsible minerals report detailing establishing a sustainable supply cha...
May 07, 2024 (Gmt+09:00)
-
Korean chipmakers
Samsung gains upper hand vs Netlist in $303 million patent dispute
Samsung Electronics Co. has taken the upper hand in its ongoing legal battle against Netlist Inc. over memory chip module patent infringement allega...
Apr 03, 2024 (Gmt+09:00)
-
Bio & Pharma
Global quest to find modern elixirs enters new chapter
NEW YORK/ BOSTON – Longevity has long been the dream of humankind. China’s first emperor Qin Shi Huang was obsessed with finding magic e...
Mar 26, 2024 (Gmt+09:00)
-
Tech, Media & Telecom
SK Telecom develops AI-powered 6G air interface
SK Telecom Co., South Korea’s leading mobile carrier, has successfully proved the efficacy of artificial intelligence technology on the improv...
Feb 22, 2024 (Gmt+09:00)
-
Tech, Media & Telecom
Studio Meta-K, Vietnam’s Synapse Studio to co-work for virtual human
South Korea’s content production startup Studio Meta-K announced on Wednesday that it signed a memorandum of understanding (MOU) with Vietna...
Feb 21, 2024 (Gmt+09:00)
-
Tech, Media & Telecom
SK Telecom to enter Australian pet clinics market in H1
South Korea’s SK Telecom Co. announced on Tuesday that it has signed a commercial contract with ATX Medical Solutions, Australia's largest m...
Feb 13, 2024 (Gmt+09:00)
-
Bio & Pharma
Aprogen gets OK Phase 3 trials in India for Herceptin biosimilar
South Korea’s biopharmaceutical company Aprogen Inc. announced on Monday that its Phase 3 clinical trial for a biosimilar of Herceptin (trastu...
Feb 05, 2024 (Gmt+09:00)
-
Electronics
LG Elec unveils OLED TV featuring world-renowned AI artist in US
LG Electronics Inc. collaborated with world-renowned artificial intelligence (AI) artist Stephanie Dinkins to showcase art pieces that explore commu...
Jan 29, 2024 (Gmt+09:00)
-
Automobiles
Hyundai Mobis unveils human-centric lighting tech for cars
Hyundai Mobis Co., the world’s sixth-largest auto parts maker, has introduced a system that changes car interior lights depending on a driver&...
Jan 24, 2024 (Gmt+09:00)
-
Bio & Pharma
JW Pharma takes gout drug Epaminurad to Malaysia for phase 3
South Korea's JW Pharmaceutical Corp., announced on Monday that it has received approval from the Malaysian National Pharmaceutical Regulatory Age...
Jan 15, 2024 (Gmt+09:00)
-
Bio & Pharma
LG Chem out-licenses obesity drug candidate to US firm
LG Chem Ltd. has agreed to license out a rare genetic obesity drug candidate in phase 2 clinical trials to Rhythm Pharmaceuticals Inc., a US biotech...
Jan 05, 2024 (Gmt+09:00)
-
Airlines
Virtual humans debut on Korean Air’s in-flight video
Korean Air Lines Co. released on Thursday a new in-flight safety video featuring a virtual human dressed as a flight attendant. This is the first ti...
Jan 04, 2024 (Gmt+09:00)
-
Bio & Pharma
MedPacto gets FDA OK for colorectal cancer drug clinical trial
South Korea's biotech company MedPacto Inc. announced on Tuesday that it has got approval from the US Food and Drug Administration (FDA) for its I...
Jan 03, 2024 (Gmt+09:00)
-
Bio & Pharma
CGBio gets FDA approval for Novosis Putty
South Korea's bio-regenerative medical firm CGBio announced on Tuesday that its Novosis Putty has been designated as a breakthrough device by the US...
Jan 02, 2024 (Gmt+09:00)
-
Upcoming IPOs
Peter Thiel-backed D&D Pharmatech gets preliminary nod for IPO
South Korean clinical-stage biotech D&D Pharmatech Inc. has won approval from the Korea Exchange’s preliminary review for listing on the j...
Dec 22, 2023 (Gmt+09:00)
-
Electronics
LG Elec launches new medical monitor
LG Electronics Inc. unveiled a new medical monitor on Wednesday. This monitor boasts high brightness suitable for both clinical and diagnostic purpo...
Dec 13, 2023 (Gmt+09:00)
-
Bio & Pharma
HK inno.N reveals differentiated clinical results for K-CAB
South Korean bio-health company HK inno.N has been expanding its market by steadily announcing differentiated clinical results for its gastroesophag...
Dec 12, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience applies Phase 3 trials in US for pneumococcal vaccine
South Korea's SK Bioscience Co. announced on Monday that it submitted the Investigational New Drug (IND) application for the Phase 3 clinical trial ...
Dec 11, 2023 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand